Aug 4 : In another milestone moment, the FDA approved Biogen and Sage Therapeutics zuranolonehenceforth Zurzuvaeas the first pill for postpartum depression (PPD)
Back to Part 1 Part 1 of the guide covers the mechanism, the portal-peripheral mismatch, and how to read the U/kg trend over time.
For now, BPC-157 remains unapproved and off-limits through licensed compounding pharmacies
GLP-1 receptor agonists like Ozempic (semaglutide) and Mounjaro (tirzepatide) have revolutionized diabetes management and weight loss treatment
Some individuals experience mild gastrointestinal side effects like nausea or changes in bowel movements during this phase, which typically resolve within 37 days as your system adapts
This may lead to decreased hunger, slower digestion, and better glucose control, all of which can help you achieve your weight-loss goalsno restrictive diet or extreme exercise regimen needed